Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Clinical trial NCT05711615 · RECRUITING

Trial details

NCT number: NCT05711615
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Dedifferentiated Liposarcoma Metastatic Leiomyosarcoma Metastatic Myxofibrosarcoma Metastatic Sarcoma Metastatic Synovial Sarcoma Metastatic Undifferentiated Pleomorphic Sarcoma Unresectable Dedifferentiated Liposarcoma Unresectable Leiomyosarcoma Unresectable Myxofibrosarcoma Unresectable Sarcoma Unresectable Synovial Sarcoma Unresectable Undifferentiated Pleomorphic Sarcoma

Start date: 2024-02-06
Primary completion: 2026-11-03
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.